Verbal cued recall as a predictor of conversion to Alzheimer's disease in Mild Cognitive Impairment
Objective This study was set up to investigate whether neuropsychological tests are able to predict conversion to AD among Mild Cognitive Impairment (MCI) patients. Methods At baseline the cognitive part of the Cambridge Examination for Mental Disorders of the Elderly (CAMCOG), the Mini Mental Statu...
Saved in:
Published in | International journal of geriatric psychiatry Vol. 24; no. 10; pp. 1094 - 1100 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
01.10.2009
Psychology Press Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objective
This study was set up to investigate whether neuropsychological tests are able to predict conversion to AD among Mild Cognitive Impairment (MCI) patients.
Methods
At baseline the cognitive part of the Cambridge Examination for Mental Disorders of the Elderly (CAMCOG), the Mini Mental Status Examination (MMSE), the Geriatric Depression Scale (GDS), a Dutch variation of Rey's Auditory Verbal Learning Test, the Memory Impairment Screen plus (MISplus) and the Visual Association Test (VAT) were administered to 40 patients diagnosed with MCI. After 18 months, MCI‐patients were reassessed and a follow‐up diagnosis was established. Of those who were seen for follow‐up (n = 31), seven fulfilled (NINCDS‐ADRDA) criteria of probable AD, while 24 did not convert.
Results
A binary logistic regression analysis showed that the MISplus contributed most to the prediction of conversion (OR = 0.28, 95% CI 0.099–0.790). With a cut‐off of 2 out of 6, a positive predictive value of 71.5%, a negative predictive value of 91.5% and an overall diagnostic accuracy of 87.0% were achieved.
Conclusions
This prospective, longitudinal study shows that a score of 0 or 1 out of 6 on the MISplus may be a good indicator of future (within 18 months) progression to AD among MCI‐patients. Copyright © 2009 John Wiley & Sons, Ltd. |
---|---|
Bibliography: | Medical Research Foundation Antwerp ark:/67375/WNG-HB8LQ8BW-5 istex:EB474B952B6F1D49AA31577F110AA05D0B68E0F5 The Institute for Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) International Alzheimer's Research Foundation (IARF) The Institute Born-Bunge Thomas Riellaerts Research Fund The Thomas Riellaerts Research Fund The Agreement between the Institute Born-Bunge and the University of Antwerp Research Fund of the Vrije Universiteit Brussel (OZR) and the Special Research Fund of the University of Antwerp The Research Foundation-Flanders (FWO-F) Neurosearch Antwerp ArticleID:GPS2228 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0885-6230 1099-1166 |
DOI: | 10.1002/gps.2228 |